These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Influence of body mass index on biochemical outcome after permanent prostate brachytherapy. Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen Z, Lief JH, Adamovich E. Urology; 2005 Jan 01; 65(1):95-100. PubMed ID: 15667872 [Abstract] [Full Text] [Related]
12. Cancer control after low-dose-rate prostate brachytherapy performed by a multidisciplinary team with no previous prostate brachytherapy experience. McMullen KP, deGuzman AF, McCullough DL, Lee WR. Urology; 2004 Jun 01; 63(6):1128-31. PubMed ID: 15183965 [Abstract] [Full Text] [Related]
13. Brachytherapy in men aged < or = 54 years with clinically localized prostate cancer. Merrick GS, Wallner KE, Butler WM, Galbreath RW, Allen ZA, Adamovich E, True L. BJU Int; 2006 Aug 01; 98(2):324-8. PubMed ID: 16879672 [Abstract] [Full Text] [Related]
14. Iodine seed prostate brachytherapy: an alternative first-line choice for early prostate cancer. Langley SE, Laing RW. Prostate Cancer Prostatic Dis; 2004 Aug 01; 7(3):201-7. PubMed ID: 15184864 [Abstract] [Full Text] [Related]
15. Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer. Morris WJ, Keyes M, Palma D, Spadinger I, McKenzie MR, Agranovich A, Pickles T, Liu M, Kwan W, Wu J, Berthelet E, Pai H. Urology; 2009 Apr 01; 73(4):860-5; discussion 865-7. PubMed ID: 19168203 [Abstract] [Full Text] [Related]
16. Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy. Eggener SE, Roehl KA, Yossepowitch O, Catalona WJ. J Urol; 2006 Oct 01; 176(4 Pt 1):1399-403. PubMed ID: 16952643 [Abstract] [Full Text] [Related]
17. Prognostic significance of perineural invasion on biochemical progression-free survival after prostate brachytherapy. Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen ZA, Adamovich E. Urology; 2005 Nov 01; 66(5):1048-53. PubMed ID: 16286122 [Abstract] [Full Text] [Related]
18. 15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience. Sylvester JE, Grimm PD, Blasko JC, Millar J, Orio PF, Skoglund S, Galbreath RW, Merrick G. Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):57-64. PubMed ID: 17084544 [Abstract] [Full Text] [Related]
19. Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005. Colberg JW, Decker RH, Khan AM, McKeon A, Wilson LD, Peschel RE. Cancer J; 2007 Jan 01; 13(4):229-32. PubMed ID: 17762756 [Abstract] [Full Text] [Related]
20. Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy. Merrick GS, Butler WM, Wallner KE, Galbreath RW, Lief JH, Adamovich E. Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1056-62. PubMed ID: 15001245 [Abstract] [Full Text] [Related] Page: [Next] [New Search]